NCT03306277: Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1
- State
- Completed
- Phase
- Phase 3
- People
- 22 taking part
- Started
- 24 Oct 2017
- Primary completion
- 12 Nov 2019
- Arms
- Onasemnogene Abeparvovec-xioi
- Results
- Posted on the registry
- 11 Oct 2017: Trial registered
- 24 Oct 2017: Trial started
- 12 Nov 2019: Trial completed
- 16 Jul 2020: Trial results posted